Intravacc
Bilthoven, Utrecht, Netherlands
Purpose
to cover the expenses for the initial activities which are necessary in order to prepare Intravacc to be ready to start to produce, test and document new Oral Polio Vaccine type 2 (nOPV2) poliovirus Master- and Working seed lots (for two concepts) to ensure future production of live polio vaccines as soon as possible after the Product Development
Division
Global Development
Date
August 2014
Region Served
EUROPE
Committed amount
$99,921
Grant topic
Polio
Duration (months)
4
Grantee location
Bilthoven, Utrecht, Netherlands
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.